Neurotransmitter Agents

"Neurotransmitter Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function.

Descriptor ID	D018377
MeSH Number(s)	D27.505.519.625 D27.505.696.577
Concept/Terms	Neurotransmitter Agents Neurotransmitter Agents Neurosteroids Neurosteroids Neuroregulators Neuroregulators Neuroregulator Neurohumors Neurohumors Neuromodulators Neuromodulators Neuromodulator Neurotransmitters Neurotransmitters Transmitter Substances, Nerve Substances, Nerve Transmitter Nerve Transmitter Substances Neurotransmitter Neurohormones Neurohormones

Below are MeSH descriptors whose meaning is more general than "Neurotransmitter Agents".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Molecular Mechanisms of Pharmacological Action [D27.505.519]
Neurotransmitter Agents [D27.505.519.625]
Physiological Effects of Drugs [D27.505.696]
Neurotransmitter Agents [D27.505.696.577]

Below are MeSH descriptors whose meaning is related to "Neurotransmitter Agents".

Below are MeSH descriptors whose meaning is more specific than "Neurotransmitter Agents".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Neurotransmitter Agents" by people in this website by year, and whether "Neurotransmitter Agents" was a major or minor topic of these publications.

Bar chart showing 109 publications over 29 distinct years, with a maximum of 9 publications in 2008

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1993	4	1	5
1994	4	1	5
1995	1	2	3
1996	0	1	1
1997	1	3	4
1998	2	2	4
1999	2	0	2
2000	1	1	2
2001	2	1	3
2002	1	4	5
2003	3	2	5
2004	0	3	3
2005	1	4	5
2006	2	4	6
2007	3	3	6
2008	3	6	9
2009	3	4	7
2010	2	3	5
2012	1	2	3
2013	1	0	1
2014	3	0	3
2015	2	1	3
2016	2	0	2
2017	1	2	3
2018	1	3	4
2019	0	1	1
2020	1	2	3
2021	1	3	4
2022	0	2	2

Below are the most recent publications written about "Neurotransmitter Agents" by people in Profiles.

Lai Y, Fois G, Flores JR, Tuvim MJ, Zhou Q, Yang K, Leitz J, Peters J, Zhang Y, Pfuetzner RA, Esquivies L, Jones P, Frick M, Dickey BF, Brunger AT. Inhibition of calcium-triggered secretion by hydrocarbon-stapled peptides. Nature. 2022 03; 603(7903):949-956.

View in: PubMed
Stahl A, Noyes NC, Boto T, Botero V, Broyles CN, Jing M, Zeng J, King LB, Li Y, Davis RL, Tomchik SM. Associative learning drives longitudinally graded presynaptic plasticity of neurotransmitter release along axonal compartments. Elife. 2022 03 14; 11.

View in: PubMed
Prossin A, Koch A, Campbell P, Laumet G, Stohler CS, Dantzer R, Zubieta JK. Effects of placebo administration on immune mechanisms and relationships with central endogenous opioid neurotransmission. Mol Psychiatry. 2022 Feb; 27(2):831-839.

View in: PubMed
Luck B, Horvath TD, Engevik KA, Ruan W, Haidacher SJ, Hoch KM, Oezguen N, Spinler JK, Haag AM, Versalovic J, Engevik MA. Neurotransmitter Profiles Are Altered in the Gut and Brain of Mice Mono-Associated with Bifidobacterium dentium. Biomolecules. 2021 07 23; 11(8).

View in: PubMed
Shakil S, Masjoan Juncos JX, Mariappan N, Zafar I, Amudhan A, Amudhan A, Aishah D, Siddiqui S, Manzoor S, Santana CM, Rumbeiha WK, Salim S, Ahmad A, Ahmad S. Behavioral and Neuronal Effects of Inhaled Bromine Gas: Oxidative Brain Stem Damage. Int J Mol Sci. 2021 Jun 12; 22(12).

View in: PubMed
Sardar D, Lozzi B, Woo J, Huang TW, Cvetkovic C, Creighton CJ, Krencik R, Deneen B. Mapping Astrocyte Transcriptional Signatures in Response to Neuroactive Compounds. Int J Mol Sci. 2021 Apr 12; 22(8).

View in: PubMed
Dono A, Patrizz A, McCormack RM, Putluri N, Ganesh BP, Kaur B, McCullough LD, Ballester LY, Esquenazi Y. Glioma induced alterations in fecal short-chain fatty acids and neurotransmitters. CNS Oncol. 2020 06; 9(2):CNS57.

View in: PubMed
Sarasamma S, Audira G, Siregar P, Malhotra N, Lai YH, Liang ST, Chen JR, Chen KH, Hsiao CD. Nanoplastics Cause Neurobehavioral Impairments, Reproductive and Oxidative Damages, and Biomarker Responses in Zebrafish: Throwing up Alarms of Wide Spread Health Risk of Exposure. Int J Mol Sci. 2020 Feb 19; 21(4).

View in: PubMed
Cai YQ, Hou YY, Pan ZZ. GluA1 in central amygdala increases pain but inhibits opioid withdrawal-induced aversion. Mol Pain. 2020 Jan-Dec; 16:1744806920911543.

View in: PubMed
Solingapuram Sai JKK, Hurley RA, Dodda M, Taber KH. Positron Emission Tomography: Updates on Imaging of Addiction. J Neuropsychiatry Clin Neurosci. 2019 Fall; 31(4):A6-288.

View in: PubMed

People

Explore

Similar Concepts

Top Journals